Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

April 30, 2013

Conditions

Colorectal Cancer (CRC)

Interventions

DRUG

NGR-hTNF

iv q3W or q1W NGR-hTNF 0.8 μg/m²

Trial Locations (3)

Istituto Clinico Humanitas, Rozzano

"Azienda Ospedaliera Universitaria San Martino", Genoa

Fondazione San Raffaele del Monte Tabor, Milan